Tiziana Life Sciences (TLSA) Earnings Analysis

Tiziana Life Sciences (TLSA) next reports earnings on 2026-09-18, consensus EPS -0.07918 USD. Last quarter (2026-05-01) it missed with EPS -0.22 USD vs -0.09053 USD est (-143%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E -4.12.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does TLSA next report earnings?

Next earnings date2026-09-18
Consensus EPS estimate-0.07918 USD
Revenue estimaten/a

TLSA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-01-0.22 USD-0.09053 USD-143%Miss
2025-07-08-0.09642 USD-0.07122 USD-35.4%Miss
2025-06-23-0.13214 USDn/an/an/a
2025-05-20-0.0649 USDn/an/an/a

Beat rate: 0/2 (0%) over reported quarters with consensus data.

TLSA valuation and analyst view

Trailing P/E-4.12
Trailing EPS-0.38 USD
Price / book2.34
Dividend yield0.00%
Market cap0.06B
Analyst consensusBuy (2 buy / 1 hold / 0 sell)

Related research pages

Frequently asked questions

When is Tiziana Life Sciences (TLSA)'s next earnings date?

Tiziana Life Sciences is next scheduled to report on 2026-09-18, with a consensus EPS estimate of -0.07918 USD.

Did TLSA beat earnings last quarter?

In its 2026-05-01 report, TLSA posted EPS of -0.22 USD versus a -0.09053 USD estimate — a miss of 143%.

What is TLSA's earnings track record?

Over the last 2 reported quarters with consensus data, TLSA beat estimates 0 times (0%).

What is TLSA's current P/E ratio and EPS?

TLSA trades at a trailing P/E of -4.12 on trailing EPS of -0.38 USD.

What do analysts rate TLSA?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell).